Literature DB >> 19398944

The role of MRI and MRSI in diagnosis, treatment selection, and post-treatment follow-up for prostate cancer.

Michael Fuchsjäger1, Oguz Akin, Amita Shukla-Dave, Darko Pucar, Hedvig Hricak.   

Abstract

Magnetic resonance imaging (MRI) is increasingly being recognized as a valuable tool for the assessment of prostate cancer. In recent years, MRI technology has matured, image acquisition and interpretation have improved, and a multitude of clinical studies have demonstrated the potential of MRI techniques for contributing to prostate cancer care. This review will provide a brief overview of MRI techniques relevant to prostate cancer, including MR spectroscopic imaging, and discuss the ways that they can aid in diagnosis, treatment selection, and post-treatment follow-up.

Entities:  

Mesh:

Year:  2009        PMID: 19398944

Source DB:  PubMed          Journal:  Clin Adv Hematol Oncol        ISSN: 1543-0790


  10 in total

1.  Pilot Study of the Use of Hybrid Multidimensional T2-Weighted Imaging-DWI for the Diagnosis of Prostate Cancer and Evaluation of Gleason Score.

Authors:  Meredith Sadinski; Gregory Karczmar; Yahui Peng; Shiyang Wang; Yulei Jiang; Milica Medved; Ambereen Yousuf; Tatjana Antic; Aytekin Oto
Journal:  AJR Am J Roentgenol       Date:  2016-06-28       Impact factor: 3.959

2.  A coupled global registration and segmentation framework with application to magnetic resonance prostate imagery.

Authors:  Yi Gao; Romeil Sandhu; Gabor Fichtinger; Allen Robert Tannenbaum
Journal:  IEEE Trans Med Imaging       Date:  2010-06-07       Impact factor: 10.048

Review 3.  Contemporary management of high-risk localized prostate cancer.

Authors:  Mark Garzotto; Arthur Y Hung
Journal:  Curr Urol Rep       Date:  2010-05       Impact factor: 3.092

4.  Hybrid multidimensional T(2) and diffusion-weighted MRI for prostate cancer detection.

Authors:  Shiyang Wang; Yahui Peng; Milica Medved; Ambereen N Yousuf; Marko K Ivancevic; Ibrahim Karademir; Yulei Jiang; Tatjana Antic; Steffen Sammet; Aytekin Oto; Gregory S Karczmar
Journal:  J Magn Reson Imaging       Date:  2013-08-01       Impact factor: 4.813

5.  Incremental value of diffusion weighted and dynamic contrast enhanced MRI in the detection of locally recurrent prostate cancer after radiation treatment: preliminary results.

Authors:  Oguz Akin; David H Gultekin; Hebert Alberto Vargas; Junting Zheng; Chaya Moskowitz; Xin Pei; Dahlia Sperling; Lawrence H Schwartz; Hedvig Hricak; Michael J Zelefsky
Journal:  Eur Radiol       Date:  2011-05-01       Impact factor: 5.315

6.  Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness.

Authors:  Hebert Alberto Vargas; Oguz Akin; Tobias Franiel; Yousef Mazaheri; Junting Zheng; Chaya Moskowitz; Kazuma Udo; James Eastham; Hedvig Hricak
Journal:  Radiology       Date:  2011-03-24       Impact factor: 11.105

7.  Multiparametric prostate MR imaging with T2-weighted, diffusion-weighted, and dynamic contrast-enhanced sequences: are all pulse sequences necessary to detect locally recurrent prostate cancer after radiation therapy?

Authors:  Olivio F Donati; Sung Il Jung; Hebert Alberto Vargas; David H Gultekin; Junting Zheng; Chaya S Moskowitz; Hedvig Hricak; Michael J Zelefsky; Oguz Akin
Journal:  Radiology       Date:  2013-03-12       Impact factor: 11.105

8.  Interactive dedicated training curriculum improves accuracy in the interpretation of MR imaging of prostate cancer.

Authors:  Oguz Akin; Christopher C Riedl; Nicole M Ishill; Chaya S Moskowitz; Jingbo Zhang; Hedvig Hricak
Journal:  Eur Radiol       Date:  2010-04       Impact factor: 5.315

9.  Semiautomatic registration of digital histopathology images to in vivo MR images in molded and unmolded prostates.

Authors:  Olga Starobinets; Richard Guo; Jeffry P Simko; Kyle Kuchinsky; John Kurhanewicz; Peter R Carroll; Kirsten L Greene; Susan M Noworolski
Journal:  J Magn Reson Imaging       Date:  2013-10-17       Impact factor: 4.813

Review 10.  Advanced imaging for the early diagnosis of local recurrence prostate cancer after radical prostatectomy.

Authors:  Valeria Panebianco; Flavio Barchetti; Daniela Musio; Francesca De Felice; Camilla Proietti; Elena Lucia Indino; Valentina Megna; Orazio Schillaci; Carlo Catalano; Vincenzo Tombolini
Journal:  Biomed Res Int       Date:  2014-03-13       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.